IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces a Class Action Lawsuit Against Endologix Inc. & Advises Investors with Lo...
January 10 2017 - 7:35PM
Business Wire
Goldberg Law PC, a national shareholder rights litigation firm,
announces that it is investigating Endologix Inc. (“Endologix” or
the “Company”) (Nasdaq: ELGX) concerning possible violations of
federal securities laws. Investors who purchased or otherwise
acquired Endologix shares between August 2, 2016 and November 16,
2016 inclusive (the “Class Period”), are encouraged to contact the
firm in advance of the March 6, 2017 lead
plaintiff motion deadline.
If you purchased or otherwise acquired Endologix shares and
would like more information regarding the investigation, we
encourage you to click here, or contact Michael Goldberg or Brian
Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100,
Los Angeles, CA 90067, at 800-977-7401, to discuss your rights
without cost to you. You can also reach us through the firm’s
website at http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
Endologix designs, manufactures and sells medical products
intended to treat abdominal aortic aneurysms.
Nellix is used as Endologix’s endovascular aneurysm sealing
system for infrarenal abdominal aortic aneurysms. Endologix stated
that it would approve the initial version of the Nellix system used
in the Nellix investigational device exemption (IDE) clinical
trial, the EVAS FORWARD-IDE Study.
On November 16, 2016 however, Endologix revealed that the FDA
requested a two-year follow-up on patients in the EVAS-FORWARD-IDE
study to accurately measure Nellix.
On December 27, 2016 Endologix revealed that it was temporarily
holding AFX Endovascular AAA System shipments, due to an
investigation of a manufacturing problem.
When this information was released to the public, the value of
Endologix fell 20%, causing investors harm.
If you have any questions concerning your legal rights, please
immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com, or email us at
info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170110006472/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.com
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Apr 2023 to Apr 2024